NCT02733328View on ClinicalTrials.gov

Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study

CompletedOBSERVATIONAL

Enrollment

405

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 17, 2018

Study Completion Date

September 7, 2020

Conditions

Acute Kidney Injury (AKI)Chronic Kidney Disease (CKD)End Stage Renal Disease (ESRD)Estimated Glomerular Filtration Rate (eGFR)Neutrophil Gelatinase-associated Lipocalin (NGAL)Serum Creatinine (SCr)Urine Creatinine (UCr)Urine Albumin (UAlb)

Interventions

PROCEDURE

CPB Surgery

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors

lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT02733328 - Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study | Biotech Hunter | Biotech Hunter